medigraphic.com
SPANISH

Revista Cubana de Medicina

ISSN 1561-302X (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 4

<< Back Next >>

Rev cubana med 2020; 59 (4)

Prognostic factors subclinical atherosclerosis in dyslipidemic patients

Herrera GA, González DD, Tamargo BTO, Soto MJ, Peña GY
Full text How to cite this article

Language: Spanish
References: 14
Page: 1-11
PDF size: 412.34 Kb.


Key words:

subclinical atherosclerosis, atheroma plaque, intima-media.

ABSTRACT

Introduction: Subclinical atherosclerosis is a predictor of future vascular events and is diagnosed by imaging and biomarkers without any clinical manifestations.
Objective: To identify the prognostic factors that are associated with subclinical atherosclerosis in dyslipidemic patients.
Method: A cohort study was carried out at the Hermanos Ameijeiras Hospital in 1028 patients in the period from 2016 to 2019.
Results: The existence of atheroma plaque was 26.9%. There were significant differences related to smoking (30.0% vs 23.7%). In the lipid variables, the average of the LDLc values ​​is higher in patients with atheroma plaque and the CT/LDL ratio is higher in those without this alteration. Regarding the frequency of thickening of the intima-media complex greater than 1.0 mm, it was 37.1%. There were significant differences related to smoking (30.4% vs 22.4%) and the presence of HTA (56.7% vs 48.8%) in the lipid variables, the average of the HDLc values ​​is higher in the patients without an increase in the thickness of the intima-media complex and the CT/HDL elevation is greater in those with said alteration.
Conclusions: The factors that independently influence the probability of atheroma plaque formation are LDLc (elevated), age, triglycerides and male sex, and those that influence the probability of thickening of the intima-media complex. They are HDLc (low), smoking, and high blood pressure.


REFERENCES

  1. Mitu O, Roca M, Floria M, Petris AO, Graur M, Mitu F. Subclinical cardiovascular disease assessment and its relationship with cardiovascular risk SCORE in a healthy adult population: A cross-sectional community-based study. Clin Investig Arterioscler. 2017[acceso: 07/09/2020];29(3):111-19. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28377040/

  2. Luirink IK, Kuipers IM, Hutten BA, Planken RN, Backx APCM, Groothoff JW, et al. Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia. Atherosclerosis. 2019[acceso: 07/09/2020];285:87-92. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31048103/

  3. Zhang P, Li D, Su Y, Wang X, Sun J, Xu Y, et al. Assessment of myocardial strain in children with risk factors for atherosclerosis with use of 3D speckle tracking echocardiography. Echocardiography. 2018[acceso: 07/09/2020];35(4):487-93. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29399870/

  4. Fernström M, Fernberg U, Eliason G, Hurtig-Wennlöf A. Aerobic fitness is associated with low cardiovascular disease risk: the impact of lifestyle on early risk factors for atherosclerosis in young healthy Swedish individuals-the Lifestyle, Biomarker, and Atherosclerosis study. Vasc Health Risk Manag. 2017[acceso: 07/09/2020];13:91-99. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28352184/

  5. Moreyra E Jr, Lorenzatti D, Moreyra C, Arias V, Tibaldi MA, Lepori AJ, et al. Comparison of risk scores to predict subclinical atherosclerosis. Medicina (B Aires). 2019[acceso: 07/09/2020];79(5):373-83. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31671387/

  6. López-Melgar B, Fernández-Friera L, Oliva B, García-Ruiz JM, Peñalvo JL, Gómez-Talavera S, et al. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. J Am Coll Cardiol. 2017[acceso: 07/09/2020];70(3):301-13. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28705310/

  7. Djekic D, Pinto R, Repsilber D, Hyotylainen T, Henein M. Serum untargeted lipidomic profiling reveals dysfunction of phospholipid metabolism in subclinical coronary artery disease. Vasc Health Risk Manag . 2019[acceso: 07/09/2020];15:123-35. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31190850/

  8. Abdaly MS, Azizi MS, Wijaya IP, Nugroho P, Purnamasari D. Subclinical Atherosclerosis in Young Adult Population with First Degree Relatives of Type 2 Diabetes Mellitus. Acta Med Indones. 2019[acceso: 07/09/2020];51(2):169-76. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31383833/

  9. Çetin M, Erdoğan T, Kırış T, Özyıldız AG, Ergül E, Durakoğlugil E, et al. Endothelial dysfunction, subclinical atherosclerosis and LDL cholesterol are the independent predictors of left atrial functions in hypertension. Int J Cardiovasc Imaging. 2020[acceso: 07/09/2020];36(1):69-77. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31586295/

  10. Spannella F, Di Pentima C, Giulietti F, Buscarini S, Ristori L, Giordano P, et al. Prevalence of Subclinical Carotid Atherosclerosis and Role of Cardiovascular Risk Factors in Older Adults: Atherosclerosis and Aging are Not Synonyms. High Blood Press Cardiovasc Prev. 2020[acceso: 07/09/2020];27(3):231-38. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/32219668/

  11. Al Rifai M, Martin SS, McEvoy JW, Nasir K, Blankstein R, Yeboah J, et al. The prevalence and correlates of subclinical atherosclerosis among adults with low-density lipoprotein cholesterol <70 mg/dL: The Multi-Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Atherosclerosis. 2018[acceso: 07/09/2020];274:61-66. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/29751286/

  12. Toth PP, Patti AM, Nikolic D, Giglio RV, Castellino G, Biancucci T, et al. Bergamot Reduces Plasma Lipids, Atherogenic Small Dense LDL, and Subclinical. Atheroscleros in Subjects with Moderate Hypercholesterolemia: A 6 Months Prospective Study. Front Pharmacol. 2016[acceso: 07/09/2020];6:299. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/26779019/

  13. Caliskan Z, Demircioglu K, Sayar S, Kahraman R, Caklili O, Ozcan FB, et al. Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima-media thickness in celiac disease. North Clin Istanb. 2019[acceso: 07/09/2020];6(3):242-47. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31650110/

  14. Zheng T, Ge B, Liu H, Chen B, Qin L, Xiao L, et al. Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China. Cardiovasc Diabetol. 2018[acceso: 07/09/2020];17(1):84. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/30007407/




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev cubana med. 2020;59